Literature DB >> 8583845

Metastatic cutaneous squamous cell carcinoma of the head and neck region.

E Tavin1, M Persky.   

Abstract

Cutaneous squamous cell carcinoma has a relatively low metastatic rate (0.5% to 16%), but patients with the disease should always be evaluated for possible regional nodal involvement. We reviewed the records of 37 patients with metastatic disease among the 388 patients with head and neck cutaneous squamous cell carcinoma who were treated at New York University Medical Center between 1961 and 1992. In this group of patients the most common primary sit was the cheek or preauricular region and the most common metastatic site was the level I neck lymph nodes. Seven patients (18%) had metastases at initial presentation. Among the remaining patients the average time to the development of metastases was 19 months. Nineteen patients (51%) had recurrence at the primary site before metastasis; 11 (30%) developed metastases with control of the primary tumor. Analysis of the records of 31 patients treated for cure revealed that 13 were treated by surgery, 2 by radiation therapy, and 16 by a combination of surgery and radiation therapy. During the mean follow-up period of 49 months, 11 (35%) of these 31 patients died of their disease. Recurrence of the primary tumor appeared to increase the risk for nodal and distant metastases.

Entities:  

Mesh:

Year:  1996        PMID: 8583845     DOI: 10.1097/00005537-199602000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Management of high-risk cutaneous squamous cell carcinoma.

Authors:  Lorraine Jennings; Chrysalyne D Schmults
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

2.  Epigenetic alterations in metastatic cutaneous carcinoma.

Authors:  Owen A Darr; Justin A Colacino; Alice L Tang; Jonathan B McHugh; Emily L Bellile; Carol R Bradford; Mark P Prince; Douglas B Chepeha; Laura S Rozek; Jeffrey S Moyer
Journal:  Head Neck       Date:  2014-06-27       Impact factor: 3.147

Review 3.  What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck.

Authors:  Michiel W M van den Brekel; Jonas A Castelijns
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

Review 4.  Metatypical basal cell carcinoma: a clinical review.

Authors:  Mauro Tarallo; Emanuele Cigna; Riccardo Frati; Sergio Delfino; Daniele Innocenzi; Umberto Fama; Annamaria Corbianco; Nicolò Scuderi
Journal:  J Exp Clin Cancer Res       Date:  2008-11-07

5.  High-risk cutaneous squamous cell carcinoma of the head and neck.

Authors:  Michael J Veness
Journal:  J Biomed Biotechnol       Date:  2007-04-03

6.  Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.

Authors:  Mateusz Szewczyk; Jakub Pazdrowski; Paweł Golusiński; Aleksandra Dańczak-Pazdrowska; Sławomir Marszałek; Wojciech Golusiński
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-13       Impact factor: 2.503

7.  Invasive head and neck cutaneous squamous cell carcinoma: clinical and histopathological characteristics, frequency of local recurrence and metastasis.

Authors:  Luiza Vasconcelos; Juliana Carneiro Melo; Hélio Amante Miot; Mariângela Esther Alencar Marques; Luciana Patricia Fernandes Abbade
Journal:  An Bras Dermatol       Date:  2014 Jul-Aug       Impact factor: 1.896

8.  Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases.

Authors:  Alberto Grammatica; Michele Tomasoni; Milena Fior; Emanuela Ulaj; Tommaso Gualtieri; Paolo Bossi; Simonetta Battocchio; Davide Lombardi; Alberto Deganello; Davide Mattavelli; Piero Nicolai; Fabio Girardi; Cesare Piazza
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-25       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.